NKAP Antikörper

Produktnummer ABIN7643555

Produktdetails anti-NKAP Antikörper

Target: NKAP (NFKB Activating Protein (NKAP))

Reaktivität: Ratte

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser NKAP Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)

Verwendungszweck: Monoclonal Antibody to NFKB Activating Protein (NKAP)

Spezifität: The antibody is a mouse monoclonal antibody raised against NKAP. It has been selected for its ability to recognize NKAP in immunohistochemical staining and western blotting.

Aufreinigung: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Anwendungsinformationen

Applikationshinweise: Western blotting: 0.2-2 μg/mL,1:500-5000 Immunohistochemistry: 5-20 μg/mL,1:50-200 Immunocytochemistry: 5-20 μg/mL,1:50-200 Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Details zu NKAP

Target: NKAP (NFKB Activating Protein (NKAP))

Andere Bezeichnung: NKAP (NKAP Produkte)

Hintergrund: NF Kappa B Activating Protein

UniProt: Q4V7C9

Pathways: Stem Cell Maintenance, Phosphorylierungen bei SARS-CoV-2 Infektion